Literature DB >> 4992458

Serological and chemical studies of Sh. sonnei, Pseudomonas shigelloides and C27 strains.

K Rauss, T Kontrohr, A Vertényi, L Szendrei.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4992458

Source DB:  PubMed          Journal:  Acta Microbiol Acad Sci Hung        ISSN: 0001-6187


× No keyword cloud information.
  5 in total

1.  Comparison of O-antigen gene clusters of Escherichia coli (Shigella) sonnei and Plesiomonas shigelloides O17: sonnei gained its current plasmid-borne O-antigen genes from P. shigelloides in a recent event.

Authors:  J G Shepherd; L Wang; P R Reeves
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  Monoclonal antibodies specific for Shigella flexneri lipopolysaccharides: clones binding to type I and type III:6,7,8 antigens, group 6 antigen, and a core epitope.

Authors:  N I Carlin; A A Lindberg
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

3.  Characterization of the Shigella serotype D (S. sonnei) O polysaccharide and the enterobacterial R1 lipopolysaccharide core by use of mouse monoclonal antibodies.

Authors:  J F Viret; U Bruderer; A B Lang
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

4.  Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids.

Authors:  D N Taylor; A C Trofa; J Sadoff; C Chu; D Bryla; J Shiloach; D Cohen; S Ashkenazi; Y Lerman; W Egan
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

5.  Monoclonal antibodies specific for Shigella flexneri lipopolysaccharides: clones binding to type IV, V, and VI antigens, group 3,4 antigen, and an epitope common to all Shigella flexneri and Shigella dysenteriae type 1 stains.

Authors:  N I Carlin; A A Lindberg
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.